Показано 0 из 0
Дата |
---|
17:27 |
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.16
|
1.17
|
1.20
|
1.13
|
1.2697
|
1.16
|
|
|
637 680.03
|
1 974.00
|
1.20
|
1.21
|
0.9097
|
0.9002
|
1.32
|
1.15
|
|
|
4 500 374.52
|
8 381.00
|
0.8625
|
0.88
|
0.80
|
0.80
|
0.9246
|
0.8848
|
|
|
887 574.87
|
2 609.00
|
0.7901
|
0.8066
|
0.73
|
0.7002
|
0.9274
|
0.8066
|
|
|
2 074 995.09
|
5 716.00
|
0.75
|
0.80
|
0.55
|
0.4222
|
0.85
|
0.7301
|
|
|
2 902 906.55
|
8 151.00
|
0.5937
|
0.608
|
1.14
|
0.55
|
1.15
|
0.6162
|
|
|
5 894 630.98
|
14 450.00
|
1.32
|
1.36
|
1.44
|
1.35
|
2.01
|
1.41
|
|
|
22 488 243.35
|
43 174.00
|
1.35
|
1.38
|
1.05
|
0.981
|
1.39
|
1.33
|
|
|
4 009 897.69
|
8 602.00
|
1.00
|
1.05
|
1.10
|
0.92
|
1.10
|
1.02
|
|
|
2 099 289.39
|
5 083.00
|
1.14
|
1.15
|
0.8104
|
0.81
|
1.20
|
1.16
|
|
|
5 120 296.04
|
12 881.00
|
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others.